Table 5.
Parameter | User's guideline | Current study | Previous study in Ethiopia | Kenya | Tanzania | Uganda | Nigeria |
---|---|---|---|---|---|---|---|
CD3+/µL | 688–1955 | 655–2823 | NA | 744–2634 | NA | NA | NA |
CD4+/µL | 500–1300 | 321–1389 | 366–1235 | 421–1550 | 312–1367 | 418–2105 | 365–1571 |
CD8+/µL | 208–796 | 220–1664 | 311–1618 | 210–1081 | 168–996 | 256–1619 | 145–884 |
CD4 : CD8 ratio/µL | 0.83–6.10 | 0.5–2.5 | 0.4–2.4 | 0.9–3.3 | 1.1–2.5 | 0.52–4.1 | 0.5–5.3 |
References in numbers | [14] | [20] | [10] | [8] | [11] |
NA = not available.